基于母亲的风险因素,预测妊娠糖尿病的第一季度预测
Argyro Syngelaki1,2, Alan Wright3, Cristina Gomez Fernandez1
1Harris Birthright Research Centre for Fetal Medicine, King's College, London, UK.
BJOG : an international journal of obstetrics and gynaecology
|February 25, 2025
概括
一个新的第一季度模型准确地使用母亲的人口统计和病史来预测妊娠期糖尿病 (GDM) 风险. 这种早期预测有助于及时进行干预,以改善妊娠结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 生殖内分泌学 生殖内分泌学
背景情况:
- 孕期糖尿病 (GDM) 是怀孕的一个严重并发症.
- 早期预测和干预对于管理GDM和改善母亲和胎儿的结果至关重要.
研究的目的:
- 开发和验证GDM的新第一季度预测模型.
- 该模型利用了母亲的人口统计特征和病史元素.
主要方法:
- 一项前性队列研究对41587名女性进行了调查.
- 开发了一个后勤回归模型,并使用五倍交叉验证进行验证.
- 评估模型性能是使用接收机操作特征曲线 (AUROC) 下的面积和检测速率 (DRs) 来进行的.
主要成果:
- 母亲的年龄,体重,身高,种族和糖尿病家族史是GDM的重要预测因素.
- 该模型表明预测风险与观察到的发病率之间存在良好的一致性 (AUROC = 0.757).
- 检测率因GDM治疗而异:胰岛素为87.2%,甲胺为80.0%,仅饮食为61.5%,查阳性率为40%.
结论:
- 对GDM的风险评估是可行的,在怀孕的第一季度使用孕产妇的风险因素.
- 开发的模型为早期GDM风险分层提供了有价值的工具.
- 早期识别有助于及时制定GDM的管理策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
152
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
152
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K


